Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 339

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

PEGylated PLGA nanoparticles for the improved delivery of doxorubicin

Open access
Park, Jason, Fong, Peter M., Lu, Jing, Russell, Kerry S., Booth, Carmen J., Saltzman, W. Mark, Fahmy, Tarek M.·2009·Nanomedicine: Nanotechnology, Biology and Medicine

Abstract

We hypothesize that the efficacy of doxorubicin can be maximized and dose-limiting cardiotoxicity minimized by controlled release from PEGylated nanoparticles. To test this hypothesis, a unique surface modification technique was used to create PEGylated PLGA nanoparticles encapsulating doxorubicin. An avidin-biotin coupling system was used to control PEG conjugation to the surface of PLGA nanoparticles, of diameter ~130 nm, loaded with doxorubicin to 5% w/w. Encapsulation in nanoparticles did not compromise the efficacy of doxorubicin; drug-loaded nanoparticles were found to be at least as potent as free doxorubicin against A20 murine B-cell lymphoma cells in culture and of comparable efficacy against subcutaneously implanted tumors. Cardiotoxicity in mice as measured by echocardiography, serum creatine kinase, and histopathology was reduced for doxorubicin-loaded nanoparticles compared to free doxorubicin. Administration of 18 mg/kg of free doxorubicin induced a 7-fold increase in creatine kinase levels and significant decreases in left ventricular fractional shortening over control animals, whereas of nanoparticle-encapsulated doxorubicin produced none of these pathological changes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nano.2009.02.002

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 339

Metadata

Authors
Park, J., Fong, P. M., Lu, J., Russell, K. S., Booth, C. J., Saltzman, W. M., & Fahmy, T. M.
Venue
Nanomedicine: Nanotechnology, Biology and Medicine
Publisher
Elsevier BV
Published
2009-12
Volume
5
Issue
4
Pages
410-418
ISSN
1549-9634 (ISSN-L)
OpenAlex
W1995650484
Cited by
339
References
22
FWCI
8.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. https://app.cochat.ai/papers/10.1016/j.nano.2009.02.002
The paper
Park, J., Fong, P. M., Lu, J., Russell, K. S., Booth, C. J., Saltzman, W. M., & Fahmy, T. M. (2009). PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomedicine: Nanotechnology, Biology and Medicine. https://doi.org/10.1016/j.nano.2009.02.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.